Free Trial

Enliven Therapeutics (ELVN) Institutional Ownership

→ His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad)
Free ELVN Stock Alerts
$17.18
+0.40 (+2.38%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Enliven Therapeutics (NASDAQ:ELVN)

Current
Institutional Ownership
Percentage
95.08%
Number of
Institutional Buyers
(last 12 months)
19
Total
Institutional Inflows
(last 12 months)
$196.27M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$7.90M
Get ELVN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enliven Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELVN Institutional Buying and Selling by Quarter

Enliven Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2024Tower Research Capital LLC TRC5,485$76K0.0%-18.8%0.013%
2/6/2024AJOVista LLC2,046$28K0.0%N/A0.005%
2/6/2024Swiss National Bank36,473$505K0.0%-10.3%0.089%
1/24/2024Mirae Asset Global Investments Co. Ltd.12,305$170K0.0%+9.1%0.030%
1/24/2024China Universal Asset Management Co. Ltd.4,763$66K0.0%N/A0.012%
1/12/2024SG Americas Securities LLC13,501$187K0.0%+17.8%0.033%
1/5/2024 Exchange Traded Concepts LLC8,708$121K0.0%+34.0%0.021%
12/6/2023Citigroup Inc.3,347$46K0.0%-69.1%0.008%
11/13/2023FMR LLC3,676,213$50.22M0.0%-8.1%8.923%
11/8/2023Swiss National Bank40,673$556K0.0%-17.3%0.099%
11/7/2023Barclays PLC13,629$186K0.0%-8.1%0.033%
10/23/2023 BML Capital Management LLC50,000$683K0.6%-32.6%0.121%
10/13/2023SG Americas Securities LLC11,460$157K0.0%N/A0.028%
8/15/2023HighVista Strategies LLC121,073$2.47M1.1%N/A0.294%
8/15/2023Commodore Capital LP2,348,272$47.93M5.4%+35.6%5.707%
8/11/2023VR Adviser LLC2,230,127$45.52M7.3%+0.7%5.423%
8/10/2023Metropolitan Life Insurance Co NY1,279$26K0.0%N/A0.003%
8/4/2023American International Group Inc.11,235$229K0.0%N/A0.027%
8/3/2023Bank of New York Mellon Corp80,924$1.65M0.0%+429.1%0.197%
8/2/2023Bank of Montreal Can191,893$3.95M0.0%N/A0.467%
7/24/2023 BML Capital Management LLC74,232$1.52M1.4%-65.0%0.181%
7/20/2023 Exchange Traded Concepts LLC6,934$142K0.0%N/A0.017%
7/18/2023 Denali Advisors LLC9,900$202K0.1%N/A0.024%
6/1/2023Prelude Capital Management LLC34,062$40K0.0%N/A0.519%
5/16/2023Fairmount Funds Management LLC1,924,938$42.16M7.2%N/A29.353%
5/16/2023Boxer Capital LLC710,644$15.56M0.8%N/A10.836%
5/15/2023Commodore Capital LP1,731,365$37.92M5.8%N/A26.401%
5/15/2023Logos Global Management LP401,229$8.79M1.3%N/A6.118%
5/12/2023Mirabella Financial Services LLP11,670$256K0.0%N/A0.178%
5/11/2023FMR LLC3,163,482$69.28M0.0%N/A48.239%
4/20/2023Dorsey Wright & Associates1,237$27K0.0%N/A0.019%
(Data available from 1/1/2016 forward)

ELVN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELVN shares?

During the previous two years, 25 institutional investors and hedge funds held shares of Enliven Therapeutics. The most heavily invested institutionals were FMR LLC ($50.22M), Commodore Capital LP ($47.93M), VR Adviser LLC ($45.52M), Fairmount Funds Management LLC ($42.16M), Boxer Capital LLC ($15.56M), Logos Global Management LP ($8.79M), and Bank of Montreal Can ($3.95M).Learn more on ELVN's institutional investors.

What percentage of Enliven Therapeutics stock is owned by institutional investors?

95.08% of Enliven Therapeutics stock is owned by institutional investors. Learn more on ELVN's institutional investor holdings.

Which institutional investors have been buying Enliven Therapeutics stock?

Of the 20 institutional investors that purchased Enliven Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($3.16M), Commodore Capital LP ($2.35M), Fairmount Funds Management LLC ($1.92M), Boxer Capital LLC ($710.64K), Logos Global Management LP ($401.23K), Bank of Montreal Can ($191.89K), and HighVista Strategies LLC ($121.07K).

How much institutional buying is happening at Enliven Therapeutics?

Institutional investors have bought a total of 9,043,009 shares in the last 24 months. This purchase volume represents approximately $196.30M in transactions.

Which Enliven Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Enliven Therapeutics stock in the last 24 months: FMR LLC ($325.40K), BML Capital Management LLC ($162.18K), Swiss National Bank ($12.70K), Citigroup Inc. ($7.48K), Tower Research Capital LLC TRC ($1.27K), and Barclays PLC ($1.20K).

How much institutional selling is happening at Enliven Therapeutics?

Institutional investors have sold a total of 510,221 shares in the last 24 months. This volume of shares sold represents approximately $7.90M in transactions.


Related Companies:
This page (NASDAQ:ELVN) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
His win rate puts Warren Buffett to shame…
Investing Daily
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace